Latest Industry Insights

In this interview, Gregory J. McKenzie, PhD, discusses the impact of antibiotics, the introduction of new bacteria into the microbiome and the potential of human breast milk-based therapeutics.

Today’s treatments for AD are limited and unsatisfactory. This article explores a drug development effort that is taking a completely different approach – not trying to cure the disease but actually repair the damage.

To learn more about how digitalization can benefit workflows in the lab and some of the innovative solutions that Eppendorf offers in this area,188金宝搏备用spoke to Ann-Claire Foetsch.

To learn more about Kai – an AI-powered personal guide and companion – and the potential benefits of using AI as a wellness tool for mental health,188金宝搏备用spoke to Alex Frenkel.

In this piece, Adam Clore explores how smart automation can help synthetic biology companies become more resilient.

The science and medicine worlds are experiencing a new revolution, and this time the protagonist is the mRNA molecule. In this article, we explore why bioplatforms support this revolution.

PerkinElmer announced the launch of a new automated gas chromatography, the GC 2400 Platform. We spoke to Suneet Chadha to learn more about this latest introduction.

Delix Therapeutics is developing non-hallucinogenic psychedelics for use as at-home medications for mental health conditions. To find out more, we spoke to the CEO, Mark Rus.

Beckley Psytech recently announced that they have dosed the first healthy volunteers in their Phase I trial of an intranasally delivered formulation of 5-MeO-DMT, named BPL-003. To find out more about their trial approach and wider research into 5-MeO-DMT, we spoke to Beckley’s chief scientific offer, Dr. Steve Wooding.

188金宝搏备用learns about the "unusual" spread of the monkeypox virus in non-endemic countries, possible vaccination strategies against the virus and if there are effective treatments available.